Visfatin/pre-B cell colony-enhancing factor immunohistochemical overexpression in oral cancers

Journal of Applied Biomedicine

Volumn 12, Issue 4, 2014, Pages 255-262

  Lin, Li Wen ^a   Lu, Yung Chuan ^a   Wang, Chao Ping ^a   Hsu, Chia Chang ^a   Lu, Li Fen ^a   Hsin, Ming Che ^a   Tsai, I Ting ^a   Chung, Fu Mei ^a   Houng, Jer Yiing ^a   Lee, Yau Jiunn ^b   Chen, Chih Yu ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b Lee's Endocrinologic Clinic   (Taiwan)

Author keywords

CD68; Hyperplasia; Oral squamous cell carcinoma; Proliferating cell nuclear antigen; Visfatin

Indexed keywords

CD68 ANTIGEN; CYCLINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CELL HYPERPLASIA; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIP CANCER; MALE; MIDDLE AGED; MOUTH CANCER; MOUTH CAVITY; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; NECK CANCER; ORAL BIOPSY; PROTEIN EXPRESSION; TONGUE CANCER;

EID: 84923320237     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.1016/j.jab.2014.08.003     Document Type: Article

References (40)

1. Adams, D.O., Hamilton, T.A., 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2, 283-318.
2. Bedavanija, A., Brieger, J., Lehr, H.A., Maurer, J., Mann, W.J., 2003. Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery. J. Neurosurg. 98, 807-811.
3. Berger, J., 2011. The age of biomedicine: current trends in traditional subjects. J. Appl. Biomed. 9, 57-61.
4. Bowman, T., Garcia, R., Turkson, J., Jove, R., 2000. STATs in oncogenesis. Oncogene 19, 2474-2488.
5. Cancer Registry Annual Report in Taiwan Area, 2006. Department of Health, The Executive Yuan, Taipei, Taiwan, 2007.
6. Dalamaga, M., Karmaniolas, K., Papadavid, E., Pelekanos, N., Sotiropoulos, G., Lekka, A., 2011. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Menopause 18, 1198-1204.
7. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y., Shimomura, I., 2005. Visfat: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-430.
8. Garten, A., Petzold, S., Körner, A., Imai, S., Kiess, W., 2009. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20, 130-138.
9. Hall, P.A., Levison, D.A., Woods, A.L., Yu, C.C., Kellock, D.B., Watkins, J.A., Barnes, D.M., Gillett, C.E., Camplejohn, R., Dover, R., et al., 1990. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin expression: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162, 285-294.
10. Hamilton, T.A., Ohmori, Y., Narumi, S., Tannenbaum, C.S., 1993. Regulation of diversity in macrophage activation. In: Lopez-Berestein, G., Klostergaard, J. (Eds.), Mononuclear Phagocytes in Cell Biology. CRC Press, New York, NY, USA, pp. 47-70.
11. Hufton, S.E., Moerkerk, P.T., Brandwijk, R., de Bruïne, A.P., Arends, J.W., Hoogenboom, H.R., 1999. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett. 463, 77-82.
12. Jia, S.H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O.D., Marshall, J.C., 2004. Pre-B cell colony enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113, 1318-1327.
13. Kim, J.G., Kim, E.O., Jeong, B.R., Min, Y.J., Park, J.W., Kim, E.S., Namgoong, I.S., Kim, Y.I., Lee, B.J., 2010. Visfatin stimulates proliferation of MCF7 human breast cancer cells. Mol. Cells 30, 341-345.
14. Kitani, T., Okuno, S., Fujisawa, H., 2003. Growth phasedependent changes in the subcellular localization of pre-Bcell colony-enhancing factor. FEBS Lett. 544, 74-78.
15. Krajewska, M., Fenoglio-Preiser, C.M., Krajewski, S., Song, K., Macdonald, J.S., Stemmerman, G., Reed, J.C., 1996. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am. J. Pathol. 149, 1449-1457.
16. Lai, F.J., Hsieh, M.C., Hsin, S.C., Lin, S.R., Guh, J.Y., Chen, H.C., Shin, S.J., 2002. The cellular localization of increased atrial natriuretic peptide mRNA and immunoreactivity in diabetic rat kidneys. J. Histochem. Cytochem. 50, 1501-1508.
17. Landis, J.R., Koch, G.G., 1977. The measurement of observer agreement for categorical data. Biometrics 33, 159-174.
18. Li, C., Shintani, S., Terakado, N., Nakashiro, K., Hamakawa, H., 2002. Infiltration of tumor-associated macrophages in human oral squamous cell carcinoma. Oncol. Rep. 9, 1219-1223.
19. Liu, M., Lawson, G., Delos, M., Jamart, J., Ide, C., Coche, E., Weynand, B., Desuter, G., Hamoir, M., Remacle, M., Marbaix, E., 2003. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki-67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck 25, 280-288.
20. Lu, L.F., Wang, C.P., Yu, T.H., Hung, W.C., Chiu, C.A., Chung, F.M., Tsai, I.T., Yang, C.Y., Cheng, Y.A., Lee, Y.J., Yeh, L.R., 2012. Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction. Cytokine 57, 74-80.
21. Luk, T., Malam, Z., Marshall, J.C., 2008. Pre-B cell colonyenhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J. Leukoc. Biol. 83, 804-816.
22. Mantovani, A., 2005. Cancer: inflammation by remote control. Nature 435, 752-753.
23. Massano, J., Regateiro, F.S., Januário, G., Ferreira, A., 2006. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 67-76.
24. Moschen, A.R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., Tilg, H., 2007. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 178, 1748-1758.
25. Moschen, A.R., Gerner, R.R., Tilg, H., 2010. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr. Pharm. Des. 16, 1913-1920.
26. Nakajima, T.E., Yamada, Y., Hamano, T., Furuta, K., Gotoda, T., Katai, H., Kato, K., Hamaguchi, T., Shimada, Y., 2009. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J. Gastroenterol. 44, 685-690.
27. Nakajima, T.E., Yamada, Y., Hamano, T., Furuta, K., Matsuda, T., Fujita, S., Kato, K., Hamaguchi, T., Shimada, Y., 2010. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci. 101, 1286-1291.
28. Nowell, M.A., Richards, P.J., Fielding, C.A., Ognjanovic, S., Topley, N., Williams, A.S., Bryant-Greenwood, G., Jones, S.A., 2006. Regulation of pre-B cell colony enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 54, 2084-2095.
29. Ogawa, I., Miyachi, M., Takata, T., Vuhahula, E., Ijuhin, N., Nikai, H., 1993. Proliferative activity of salivary gland pleomorphic adenoma and myoepithelioma as evaluated by the proliferating cell nuclear antigen (PCNA) labeling index (LI). J. Oral Pathol. Med. 22, 447-450.
30. Patel, S.T., Mistry, T., Brown, J.E., Digby, J.E., Adya, R., Desai, K.M., Randeva, H.S., 2010. A novel role for the adipokine visfatin/ pre-B cell colony-enhancing factor 1 in prostate carcinogenesis. Peptides 31, 51-57.
31. Reddy, P.S., Umesh, S., Thota, B., Tandon, A., Pandey, P., Hegde, A.S., Balasubramaniam, A., Chandramouli, B.A., Santosh, V., Rao, M.R., Kondaiah, P., Somasundaram, K., 2008. PBEF1/ NAmPRTase/visfatin: a potential malignant astrocytoma/ glioblastoma serum marker with prognostic value. Cancer Biol. Ther. 7, 663-668.
32. Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., McNiece, I., 1994. Cloning and characterization of the cDNA encoding a novel human pre-B cell colony enhancing factor. Mol. Cell. Biol. 14, 1431-1437.
33. Shackelford, R.E., Bui, M.M., Coppola, D., Hakam, A., 2010. Overexpression of nicotinamide phosphoribosyl transferase in ovarian cancers. Int. J. Clin. Exp. Pathol. 3, 522-527.
34. Sommer, G., Garten, A., Petzold, S., Beck-Sickinger, A.G., Blüher, M., Stumvoll, M., Fasshauer, M., 2008. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin. Sci. (Lond.) 115, 13-23.
35. Tilg, H., Moschen, A.R., 2008. Role of adiponectin and PBEF/ visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin. Sci. (Lond.) 114, 275-288.
36. Tsai, Y.D., Wang, C.P., Chen, C.Y., Lin, L.W., Lin, T.M., Hsu, C.C., Chung, F.M., Lin, H.C., Hsu, H.F., Lee, Y.J., Houng, J.Y., 2013. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in male oral squamous cell carcinoma patients. Med. Oral Patol. Oral Cir. Bucal. 18, e180-e186.
37. Van Beijnum, J.R., Moerkerk, P.T., Gerbers, A.J., De Bruïne, A.P., Arends, J.W., Hoogenboom, H.R., Hufton, S.E., 2002. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int. J. Cancer 101, 118-127.
38. Wahi, P.N., Kapur, V.L., Luthra, U.K., Srivastava, M.C., 1966. Submucous fibrosis of the oral cavity. 2. Studies on epidemiology. Bull. World Health Organ. 35, 793-799.
39. Yang, H., Yang, T., Baur, J.A., Perez, E., Matsui, T., Carmona, J.J., Lamming, D.W., Souza-Pinto, N.C., Bohr, V.A., Rosenzweig, A., de Cabo, R., Sauve, A.A., Sinclair, D.A., 2007. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107.
40. Zhao, Y., Zhang, J., Xia, H., Zhang, B., Jiang, T., Wang, J., Chen, X., Wang, Y., 2012. Stat3 is involved in the motility, metastasis and prognosis in lingual squamous cell carcinoma. Cell Biochem. Funct. 30, 340-346.